The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.

Grantmaking would be decided by political appointees instead of experts

The proposed rule could “weaken the NIH’s benign influence over research risks,” writes Doni Bloomfield.